Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 138,224 | 982,923 | 1,775,442 | 296,060 | 192,580 |
| Cost of Goods | 83,567 | 377,772 | 173,348 | 86,729 | 88,283 |
| Gross Profit | 54,658 | 605,151 | 1,602,094 | 209,331 | 104,297 |
| Operating Expenses | 848,170 | 1,009,082 | 1,657,264 | 778,909 | 667,254 |
| Operating Income | -792,946 | -403,159 | -54,821 | -568,849 | -562,674 |
| Interest Expense | 13,109 | 5,855 | 29,456 | 7,946 | 35,714 |
| Other Income | 141,150 | 117,642 | 113,150 | 119,650 | 129,159 |
| Pre-tax Income | -664,904 | -291,373 | 28,872 | -457,145 | -469,229 |
| Income Tax | -42,369 | 83,550 | 62,419 | -18,277 | -31,184 |
| Net Income Continuous | -622,536 | -374,923 | -33,547 | -438,868 | -438,045 |
| Net Income | $-622,536 | $-374,923 | $-33,547 | $-438,868 | $-438,045 |
| EPS Basic Total Ops | -2.46 | -1.54 | -0.14 | -1.82 | -1.82 |
| EPS Basic Continuous Ops | -2.46 | -1.54 | -0.14 | -1.82 | -1.82 |
| EPS Diluted Total Ops | -2.46 | -1.54 | -0.14 | -1.82 | -1.82 |
| EPS Diluted Continuous Ops | -2.46 | -1.54 | -0.14 | -1.82 | -1.82 |
| EPS Diluted Before Non-Recurring Items | -2.28 | -0.38 | -0.14 | -1.82 | -1.82 |
| EBITDA(a) | $-650,977 | $-224,880 | $93,517 | $-507,457 | $-517,585 |